- Home
- IMAB vs RCON Comparison
IMAB vs RCON Comparison
Compare IMAB & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- RCON
- Stock Information
- Founded
- IMAB 2014
- RCON 2007
- Country
- IMAB United States
- RCON China
- Employees
- IMAB N/A
- RCON N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- RCON Oilfield Services/Equipment
- Sector
- IMAB Health Care
- RCON Energy
- Exchange
- IMAB Nasdaq
- RCON Nasdaq
- Market Cap
- IMAB 83.8M
- RCON 82.6M
- IPO Year
- IMAB 2020
- RCON 2009
- Fundamental
- Price
- IMAB $1.06
- RCON $2.30
- Analyst Decision
- IMAB Strong Buy
- RCON
- Analyst Count
- IMAB 3
- RCON 0
- Target Price
- IMAB $8.00
- RCON N/A
- AVG Volume (30 Days)
- IMAB 410.6K
- RCON 16.6K
- Earning Date
- IMAB 08-28-2024
- RCON 06-28-2024
- Dividend Yield
- IMAB N/A
- RCON N/A
- EPS Growth
- IMAB N/A
- RCON N/A
- EPS
- IMAB N/A
- RCON N/A
- Revenue
- IMAB $3,492,091.00
- RCON $9,475,055.00
- Revenue This Year
- IMAB N/A
- RCON N/A
- Revenue Next Year
- IMAB N/A
- RCON N/A
- P/E Ratio
- IMAB N/A
- RCON N/A
- Revenue Growth
- IMAB N/A
- RCON 2.59
- 52 Week Low
- IMAB $0.99
- RCON $1.26
- 52 Week High
- IMAB $2.54
- RCON $5.58
- Technical
- Relative Strength Index (RSI)
- IMAB 40.43
- RCON 36.87
- Support Level
- IMAB $1.02
- RCON $2.40
- Resistance Level
- IMAB $1.12
- RCON $2.80
- Average True Range (ATR)
- IMAB 0.08
- RCON 0.31
- MACD
- IMAB -0.01
- RCON -0.04
- Stochastic Oscillator
- IMAB 20.00
- RCON 15.38
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.